Cost of Revenue in USD of BIOTRICITY INC. from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biotricity Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2018 to Q3 2025.
  • Biotricity Inc. Cost of Revenue for the quarter ending September 30, 2025 was $704K, a 12.8% decline year-over-year.
  • Biotricity Inc. Cost of Revenue for the twelve months ending September 30, 2025 was $3.04M, a 9.42% decline year-over-year.
  • Biotricity Inc. annual Cost of Revenue for 2024 was $3.23M, a 13% decline from 2023.
  • Biotricity Inc. annual Cost of Revenue for 2023 was $3.71M, a 11.7% decline from 2022.
  • Biotricity Inc. annual Cost of Revenue for 2022 was $4.2M, a 36.3% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

BIOTRICITY INC. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3.04M $704K -$103K -12.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $3.14M $757K -$81.4K -9.71% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $3.23M $724K -$182K -20% Jan 1, 2025 Mar 31, 2025 10-K/A 2025-07-18
Q4 2024 $3.41M $855K +$50.2K +6.23% Oct 1, 2024 Dec 31, 2024 10-Q/A 2025-02-20
Q3 2024 $3.36M $808K -$84.3K -9.46% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $3.44M $839K -$265K -24% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $3.71M $906K -$302K -25% Jan 1, 2024 Mar 31, 2024 10-K/A 2025-07-18
Q4 2023 $4.01M $805K -$252K -23.9% Oct 1, 2023 Dec 31, 2023 10-Q/A 2025-02-20
Q3 2023 $4.26M $892K -$209K -19% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $4.47M $1.1M +$273K +32.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $4.2M $1.21M +$500K +70.6% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-27
Q4 2022 $3.7M $1.06M -$48.1K -4.35% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 $3.75M $1.1M +$428K +63.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.32M $831K +$237K +39.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.08M $708K +$266K +60.2% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-29
Q4 2021 $2.81M $1.11M +$246K +28.6% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $2.57M $673K +$63.4K +10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.5M $594K +$393K +195% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.11M $442K -$124K -22% Jan 1, 2021 Mar 31, 2021 10-K 2022-07-14
Q4 2020 $2.24M $859K +$759K +753% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $1.48M $609K +$495K +433% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $983K $201K +$50.8K +33.7% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-08-17
Q1 2020 $932K $566K Jan 1, 2020 Mar 31, 2020 10-K 2021-06-22
Q4 2019 $101K +$73.3K +266% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $114K +$86.7K +315% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $151K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q4 2018 $27.5K Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-19
Q3 2018 $27.5K Jul 1, 2018 Sep 30, 2018 10-Q 2020-02-14

BIOTRICITY INC. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.23M -$481K -13% Apr 1, 2024 Mar 31, 2025 10-K/A 2025-07-18
2023 $3.71M -$490K -11.7% Apr 1, 2023 Mar 31, 2024 10-K/A 2025-07-18
2022 $4.2M +$1.12M +36.3% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-27
2021 $3.08M +$968K +45.8% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 $2.11M +$1.18M +127% Apr 1, 2020 Mar 31, 2021 10-K 2022-07-14
2019 $932K +$594K +175% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-22
2018 $338K Apr 1, 2018 Mar 31, 2019 10-K 2020-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.